Lightnews — Scholar-powered news

Reposted by Cardiac Interventions Today

Endovascular Today @evtoday.bsky.social · 20d

Imperative Care Presents Symphony Thrombectomy System Pivotal Trial in Acute PE

evtoday.com/news/imperat...

Imperative Care Presents Symphony Thrombectomy System Pivotal Trial in Acute PE - Endovascular Today

September 18, 2025—Imperative Care, Inc. announced efficacy and safety results from the pivotal SYMPHONY-PE trial. The prospective, multicenter

evtoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Sep 5

Laza’s AI Heart Model Marks FIH Use in Ultrasound-Guided Cardiac Procedures

Laza’s AI Heart Model Marks FIH Use in Ultrasound-Guided Cardiac Procedures - Cardiac Interventions Today

September 3, 2025—Laza Medical, Inc., which is developing artificial intelligence (AI)–powered robotic ultrasound image guidance technolog

citoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Sep 2

Imperative Care Symphony Thrombectomy System Cleared for PE

Imperative Care’s Symphony Thrombectomy System Cleared for PE - Cardiac Interventions Today

September 2, 2025—Imperative Care, Inc. announced it has received FDA 510(k) clearance of its Symphony thrombectomy system to treat pulmonary em

citoday.com

1 1

Cardiac Interventions Today @citoday.bsky.social · Aug 26

Artrya’s Salix Coronary Plaque Module Cleared by FDA

Artrya’s Salix Coronary Plaque Module Cleared by FDA - Cardiac Interventions Today

August 25, 2025—Artrya Limited announced it has received 510(k) clearance from the FDA for the Salix coronary plaque module. The module is part

citoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Aug 26

FDA Begins Real-Time Reporting of Adverse Event Data

FDA Begins Real-Time Reporting of Adverse Event Data - Cardiac Interventions Today

August 25, 2025—The FDA announced it has commenced daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS).

citoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Aug 25

Otsuka Medical Devices Announces Japan Approval of Paradise uRDN System
citoday.com/news/otsuka-...

Otsuka Medical Devices Announces Japan Approval of Paradise uRDN System - Cardiac Interventions Today

August 25, 2025—Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturi

citoday.com

1 1 1

Cardiac Interventions Today @citoday.bsky.social · Aug 11

Gentuity and GE HealthCare to Collaborate on Intravascular Imaging Platform Commercialization

Gentuity and GE HealthCare to Collaborate on Intravascular Imaging Platform Commercialization - Cardiac Interventions Today

August 11, 2025—Gentuity LLC, a developer of intravascular imaging devices, recently announced an agreement with GE HealthCare to collaborate on

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jul 31

In our conversation with Dr. Babar Basir, he recounts the impact of the first decade of The National Cardiogenic Shock Initiative and shares insights into what’s on the horizon for this initiative.

A Decade of Quality Improvement: The National Cardiogenic Shock Initiative - Cardiac Interventions Today

Babar Basir, DO, FACC, FSCAI, shares insights into the development and growth of the NCSI, discussing its impact on cardiogenic shock care over the past 10 years, as well as future endeavors.

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jul 28

We spoke with SCAI President Srihari S. Naidu, MD, about his ambitious passion project in challenging the interventional cardiology field to achieve a 24-hour door-to-lactate clearance in cardiogenic shock care. @scainews.bsky.social

A Cardiogenic Shock Challenge: Achieving 24-Hour Door-to-Lactate Clearance - Cardiac Interventions Today

SCAI President Srihari S. Naidu, MD, is challenging the interventional cardiology field and all members of the shock team to achieve a door-to-lactate clearance of 24 hours to improve cardiogenic shoc...

citoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Jul 17

Biosensors Imperia Delivery System Receives CE Mark Approval

Biosensors Imperia Delivery System Receives CE Mark Approval - Cardiac Interventions Today

July 17, 2025—Biosensors International recently announced it received CE Mark certification for the Imperia delivery system under the European U

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jul 11

CMS Approves Coverage for T-TEER to Treat Tricuspid Regurgitation

CMS Approves Coverage for T-TEER to Treat Tricuspid Regurgitation - Cardiac Interventions Today

July 11, 2025—The United States Centers for Medicare & Medicaid Services (CMS) recently announced it has issued a National Coverage Determin

citoday.com

Reposted by Cardiac Interventions Today

Endovascular Today @evtoday.bsky.social · Jul 8

Medtronic’s SPYRAL GEMINI Multiorgan Denervation Study Begins Enrollment
evtoday.com/news/medtron...

Medtronic’s SPYRAL GEMINI Multiorgan Denervation Study Begins Enrollment - Endovascular Today

July 7, 2025—Medtronic announced that the first patient has been treated in its SPYRAL GEMINI global pilot study, which will investigate the saf

evtoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Jul 3

MiRus Siegel 8-F TAVR System Evaluated in Early Feasibility Study

MiRus Siegel 8-F TAVR System Evaluated in Early Feasibility Study - Cardiac Interventions Today

July 2, 2025—MiRus, LLC, announced the presentation of 30-day results from the United States early feasibility study (EFS) of the company’

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 30

Foldax Tria Mitral Valve Evaluated in Clinical Trial
citoday.com/news/foldaxs...

Foldax Tria Mitral Valve Evaluated in Clinical Trial - Cardiac Interventions Today

June 27, 2025—Foldax Inc., a Utah-based developer of polymer heart valves, announced 1-year results from a clinical trial in India of the compan

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 24

Evoque Tricuspid Valve Replacement System From Edwards Lifesciences Approved in Canada citoday.com/news/edwards...

Evoque Tricuspid Valve Replacement System From Edwards Approved in Canada - Cardiac Interventions Today

June 24, 2025—Edwards Lifesciences Corporation announced that the company’s Evoque tricuspid valve replacement system has received Health

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 16

Our new issue, introduced by Eric A. Secemsky, MD, explores what we know and what we can learn about radiation and musculoskeletal safety and how we can protect ourselves. PLUS: Hypertension therapy.
citoday.com/articles/202...

Radiation and Musculoskeletal Safety - Cardiac Interventions Today

As interventional cardiologists, we are tasked with providing the best care to our patients, oftentimes while putting our own health and safety at

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 16

In a roundtable discussion, Drs. Eric H. Yang and Ashley Stein-Merlob from the UCLA Cardio-Oncology Program do a deep dive into building a #cardioonc practice
citoday.com/articles/202...

Building a Cardio-Oncology Practice - Cardiac Interventions Today

A discussion of first steps, getting buy-in from administration and colleagues, essential support staff and service lines, building and maintaining relationships, obtaining referrals, raising awarenes...

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 12

ACC and BIDMC Smith Center Collaborate on Renal Denervation Registry
evtoday.com/news/acc-and...

ACC and BIDMC Smith Center Collaborate on Renal Denervation Registry - Endovascular Today

June 10, 2025—The American College of Cardiology (ACC) reported that the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Isra

evtoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Jun 10

1-Year Results Reported for Jenscare JensClip | #EuroPCR2025
citoday.com/news/1-year-...

1-Year Results Reported for Jenscare JensClip - Cardiac Interventions Today

June 9, 2025—Jenscare Scientific Co., Ltd. recently announced that 1-year outcomes from a study of the JensClip transcatheter mitral valve repla

citoday.com

Cardiac Interventions Today @citoday.bsky.social · Jun 9

Predictions from Drs. Orly Leiva Jr and Sara C. Martinez for the future of #cardioonc: increased presence in training programs, more outcomes data, improved QOLs, & greater influence in interventional cardiology. | @leivaorly.bsky.social @entropymama.bsky.social‬

Future Focus: Predictions for the Cardio-Oncology Field in 10 Years - Cardiac Interventions Today

The next decade of cardio-oncology is likely to include an increased presence in training programs, more outcomes data for intervention in specific cardiovascular presentations, improved patient quali...

citoday.com

1

Cardiac Interventions Today @citoday.bsky.social · Jun 5

In our latest digital exclusive series, we explore cardio-oncology from the lens of the interventional cardiologist. Read more here! #cardioonc

Cardio-Oncology in the Cath Lab

The role of the interventional cardiologist, building a practice, and the future of the subspecialty.

www.linkedin.com

Cardiac Interventions Today @citoday.bsky.social · Jun 2

An interview with leading interventional cardio-oncology experts Mehmet Çilingiroğlu, MD; Konstantinos Marmagkiolis, MD; and Cezar Iliescu, MD, ponders the role of ICs in the #cardioonc field, offers advice for treating cancer patients in the cath lab, and more.

Exploring the Role of Interventional Cardiologists in Cardio-Oncology - Cardiac Interventions Today

Leading experts in cardio-oncology discuss where the interventional cardiologist fits in the cardio-oncology field, challenges to treating cancer patients in the cath lab, treatment considerations for...

citoday.com

Cardiac Interventions Today @citoday.bsky.social · May 29

🌟 New Issue 🌟 Our digital exclusive series looks at cardio-oncology from the lens of an interventional cardiologist, with expert insights on treating cancer patients in the cath lab, predictions for the next decade, & building your own practice. #cardioonc

2025 Digital Exclusive No. 2 Issue - Cardiac Interventions Today

News and information on minimally invasive coronary disease therapies, covering valvular, structural, radial access, chronic total occlusion, and imaging issues.

citoday.com

Cardiac Interventions Today @citoday.bsky.social · May 27

Abbott’s Tendyne TMVR System Approved by FDA
citoday.com/news/abbotts...

Abbott’s Tendyne TMVR System Approved by FDA - Cardiac Interventions Today

May 27, 2025—Abbott announced FDA approval of the company’s Tendyne transcatheter mitral valve replacement (TMVR) system for the treatment

citoday.com